579
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Blocking SLC7A11 attenuates the proliferation of esophageal squamous cell carcinoma cells

, , , , , , & show all
Pages 237-250 | Received 20 Jan 2024, Accepted 18 Apr 2024, Published online: 11 May 2024

References

  • Abroun S, Saki N, Ahmadvand M, Asghari F, Salari F, Rahim F. 2015. Stats: an old story, yet mesmerizing. Cell J Fall. 17:395–411. Epub 2015/10/16.
  • Battaglia AM, Sacco A, Perrotta ID, Faniello MC, Scalise M, Torella D, Levi S, Costanzo F, Biamonte F. 2022. Iron administration overcomes resistance to Erastin-mediated ferroptosis in ovarian cancer cells. Front Oncol. 12:868351. Epub 2022/04/19.
  • Cao Y, Zhang H, Tang J, Wang R. 2022. Ferulic acid mitigates growth and invasion of esophageal squamous cell carcinoma through inducing ferroptotic cell death. Dis Markers. 2022:4607966. Epub 2022/10/22.
  • Chen T, Xu B, Chen H, Sun Y, Song J, Sun X, Zhang X, Hua W. 2022. Transcription factor NFE2L3 promotes the proliferation of esophageal squamous cell carcinoma cells and causes radiotherapy resistance by regulating IL-6. Comput Methods Programs Biomed Nov 226. 107102. Epub 2022/09/16. doi:10.1016/j.cmpb.2022.107102.
  • Deng L, Liu J, Chen WD, Wang YD. 2023. Roles of nuclear receptors in esophageal cancer. Curr Pharm Biotechnol Feb 2. 24(12):1489–1503.
  • Deng L, Zhang X, Xiang X, Xiong R, Xiao D, Chen Z, Liu K, Feng G. 2021. Nanog promotes cell proliferation, invasion, and stemness via IL-6/STAT3 signaling in esophageal squamous carcinoma. Technol Cancer Res Treat Jan-Dec. 20:15330338211038492. Epub 2021/09/15.
  • Dixon SJ, Lemberg KM, Lamprecht MR, Skouta R, Zaitsev EM, Gleason CE, Patel DN, Bauer AJ, Cantley AM, Yang WS, et al. 2012. Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell May 25. 149:1060–1072. Epub 2012/05/29. doi:10.1016/j.cell.2012.03.042.
  • Feng L, Zhao K, Sun L, Yin X, Zhang J, Liu C, Li B. 2021. SLC7A11 regulated by NRF2 modulates esophageal squamous cell carcinoma radiosensitivity by inhibiting ferroptosis. J Translational Med Aug 26. 19:367. Epub 2021/08/28. doi:10.1186/s12967-021-03042-7.
  • Han J, Guo X, Zhao L, Zhang H, Ma S, Li Y, Zhao D, Wang J, Xue F. 2023. Development and validation of esophageal squamous cell carcinoma risk prediction models based on an endoscopic screening program. JAMA Netw Open Jan 3. 6:e2253148. Epub 2023/01/27.
  • Koppula P, Zhang Y, Zhuang L, Gan B. 2018. Amino acid transporter SLC7A11/xCT at the crossroads of regulating redox homeostasis and nutrient dependency of cancer. Cancer Commun (Lond) Apr 25. 38:12. Epub 2018/05/17.
  • Lin Z, Song J, Gao Y, Huang S, Dou R, Zhong P, Huang G, Han L, Zheng J, Zhang X, et al. 2022. Hypoxia-induced HIF-1α/lncRNA-PMAN inhibits ferroptosis by promoting the cytoplasmic translocation of ELAVL1 in peritoneal dissemination from gastric cancer. Redox Biology Jun. 52:102312. Epub 2022/04/22. doi:10.1016/j.redox.2022.102312.
  • Mao C, Liu X, Zhang Y, Lei G, Yan Y, Lee H, Koppula P, Wu S, Zhuang L, Fang B, et al. 2021a. Author correction: DHODH-mediated ferroptosis defence is a targetable vulnerability in cancer. Nature Aug. 596:E13. Epub 2021/08/04.
  • Mao C, Liu X, Zhang Y, Lei G, Yan Y, Lee H, Koppula P, Wu S, Zhuang L, Fang B, et al. 2021b. DHODH-mediated ferroptosis defence is a targetable vulnerability in cancer. Nature May. 593:586–590. Epub 2021/05/14. doi:10.1038/s41586-021-03539-7.
  • Miller KD, Nogueira L, Devasia T, Mariotto AB, Yabroff KR, Jemal A, Kramer J, Siegel RL. 2022. Cancer treatment and survivorship statistics, 2022. CA Cancer J Clin Sep. 72:409–436. Epub 2022/06/24. doi:10.3322/caac.21731.
  • Miyata H, Yoshioka A, Yamasaki M, Nushijima Y, Takiguchi S, Fujiwara Y, Nishida T, Mano M, Mori M, Doki Y. 2009. Tumor budding in tumor invasive front predicts prognosis and survival of patients with esophageal squamous cell carcinomas receiving neoadjuvant chemotherapy. Cancer Jul 15. 115:3324–3334. Epub 2009/05/20. doi:10.1002/cncr.24390.
  • Pan C, Chen G, Zhao X, Xu X, Liu J. 2022. lncRNA BBOX1-AS1 silencing inhibits esophageal squamous cell cancer progression by promoting ferroptosis via miR-513a-3p/SLC7A11 axis. Eur J Pharmacol Nov 5. 934:175317. Epub 2022/10/11. doi:10.1016/j.ejphar.2022.175317.
  • Qian Y, Liang X, Kong P, Cheng Y, Cui H, Yan T, Wang J, Zhang L, Liu Y, Guo S, et al. 2020. Elevated DHODH expression promotes cell proliferation via stabilizing β-catenin in esophageal squamous cell carcinoma. Cell Death Dis Oct 15. 11:862. Epub 2020/10/17. doi:10.1038/s41419-020-03044-1.
  • Sato H, Tamba M, Kuriyama-Matsumura K, Okuno S, Bannai S. 2000. Molecular cloning and expression of human xCT, the light chain of amino acid transport system xc. Antioxid Redox Signal Winter. 2:665–671. Epub 2001/02/24. doi:10.1089/ars.2000.2.4-665.
  • Shi ZZ, Wang WJ, Chen YX, Fan ZW, Xie XF, Yang LY, Chang C, Cai Y, Hao JJ, Wang MR, et al. 2020. The miR-1224-5p/TNS4/EGFR axis inhibits tumour progression in oesophageal squamous cell carcinoma. Cell Death Dis Jul 30. 11:597. Epub 2020/08/01. doi:10.1038/s41419-020-02801-6.
  • Shiozaki A, Iitaka D, Ichikawa D, Nakashima S, Fujiwara H, Okamoto K, Kubota T, Komatsu S, Kosuga T, Takeshita H, et al. 2014. xCT, component of cysteine/glutamate transporter, as an independent prognostic factor in human esophageal squamous cell carcinoma. J Gastroenterol May. 49:853–863. Epub 2013/06/19. doi:10.1007/s00535-013-0847-5.
  • Shishido Y, Amisaki M, Matsumi Y, Yakura H, Nakayama Y, Miyauchi W, Miyatani K, Matsunaga T, Hanaki T, Kihara K, et al. 2021. Antitumor effect of 5-aminolevulinic acid through ferroptosis in esophageal squamous cell carcinoma. Ann Surgical Oncol Jul 28. 3996–4006. Epub 2020/11/20. doi:10.1245/s10434-020-09334-4
  • Shu Z, Guo J, Xue Q, Tang Q, Zhang B. 2022. Single-cell profiling reveals that SAA1+ epithelial cells promote distant metastasis of esophageal squamous cell carcinoma. Front Oncol. 12:1099271. Epub 2023/01/07.
  • Wang L, Wang C, Li X, Tao Z, Zhu W, Su Y, Choi WS. 2023. Melatonin and erastin emerge synergistic anti-tumor effects on oral squamous cell carcinoma by inducing apoptosis, ferroptosis, and inhibiting autophagy through promoting ROS. Cell Mol Biol Lett May 2. 28:36. Epub 2023/05/03. doi:10.1186/s11658-023-00449-6
  • Wu M, Tong CWS, Yan W, To KKW, Cho WCS. 2019. The RNA binding protein HuR: A promising drug target for anticancer therapy. Curr Cancer Drug Targets. 19:382–399. Epub 2018/11/02.
  • Wu Z, Geng Y, Lu X, Shi Y, Wu G, Zhang M, Shan B, Pan H, Yuan J. 2019. Chaperone-mediated autophagy is involved in the execution of ferroptosis. Proc Natl Acad Sci U S A Feb 19. 116:2996–3005. Epub 2019/02/06. doi:10.1073/pnas.1819728116.
  • Xu X, Song C, Chen Z, Yu C, Wang Y, Tang Y, Luo J. 2018. Downregulation of HuR inhibits the progression of esophageal cancer through Interleukin-18. Cancer Res Treat Jan. 50:71–87. Epub 2017/02/25. doi:10.4143/crt.2017.013.
  • Xu Z, Tie X, Li N, Yi Z, Shen F, Zhang Y. 2020. Circular RNA hsa_circ_0000654 promotes esophageal squamous cell carcinoma progression by regulating the miR-149-5p/IL-6/STAT3 pathway. IUBMB Life Mar. 72:426–439. Epub 2019/11/30. doi:10.1002/iub.2202.
  • Yan B, Guo J, Wang Z, Ning J, Wang H, Shu L, Hu K, Chen L, Shi Y, Zhang L, et al. 2023. The ubiquitin-specific protease 5 mediated deubiquitination of LSH links metabolic regulation of ferroptosis to hepatocellular carcinoma progression. MedComm Aug. 4:e337. Epub 2023/07/26.
  • Yang G, Sheng B, Li R, Xu Q, Zhang L, Lu Z. 2022. Dehydrocostus lactone induces apoptosis and cell cycle arrest through regulation of JAK2/STAT3/PLK1 signaling pathway in human esophageal squamous cell carcinoma cells. Anticancer Agents Med Chem. 22:1742–1752. Epub 2021/08/07.
  • Yang WS, SriRamaratnam R, Welsch ME, Shimada K, Skouta R, Viswanathan VS, Cheah JH, Clemons PA, Shamji AF, Clish CB, et al. 2014. Regulation of ferroptotic cancer cell death by GPX4. Cell Jan 16. 156:317–331. Epub 2014/01/21. doi:10.1016/j.cell.2013.12.010.
  • Yang YM, Hong P, Xu WW, He QY, Li B. 2020. Advances in targeted therapy for esophageal cancer. Signal Transduct Target Ther Oct 7. 5:229. Epub 2020/10/09. doi:10.1038/s41392-020-00323-3.
  • Zerbato B, Gobbi M, Ludwig T, Brancato V, Pessina A, Brambilla L, Wegner A, Chiaradonna F. 2023. PGM3 inhibition shows cooperative effects with erastin inducing pancreatic cancer cell death via activation of the unfolded protein response. Front Oncol. 13:1125855. Epub 2023/06/01.
  • Zhang W, Lin X, Chen S. 2022. Cysteinyl-tRNA synthetase 1 promotes ferroptosis-induced cell death via regulating GPX4 expression. J Oncol. 2022(4849174).
  • Zhao M, Li M, Zheng Y, Hu Z, Liang J, Bi G, Bian Y, Sui Q, Zhan C, Lin M, et al. 2022. Identification and analysis of a prognostic ferroptosis and iron-metabolism signature for esophageal squamous cell carcinoma. J Cancer. 13:1611–1622. Epub 2022/04/05.